Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Stuck in a balancing act: histone methyltransferase activity of KMT1A traps alveolar rhabdomyosarcomas in an undifferentiated state.

× No keyword cloud information.

11 in total

1. Histone methyltransferase Suv39h1 represses MyoD-stimulated myogenic differentiation.

Authors: Asoke K Mal
Journal: EMBO J Date: 2006-07-13 Impact factor: 11.598

Review 2. The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription.

Authors: Stephen J Tapscott
Journal: Development Date: 2005-06 Impact factor: 6.868

3. Histone methyltransferase KMT1A restrains entry of alveolar rhabdomyosarcoma cells into a myogenic differentiated state.

Authors: Min-Hyung Lee; Mathivanan Jothi; Andrei V Gudkov; Asoke K Mal
Journal: Cancer Res Date: 2011-04-14 Impact factor: 12.701

4. Expression of a single transfected cDNA converts fibroblasts to myoblasts.

Authors: R L Davis; H Weintraub; A B Lassar
Journal: Cell Date: 1987-12-24 Impact factor: 41.582

Review 5. Myogenesis and rhabdomyosarcoma the Jekyll and Hyde of skeletal muscle.

Authors: Raya Saab; Sheri L Spunt; Stephen X Skapek
Journal: Curr Top Dev Biol Date: 2011 Impact factor: 4.897

6. Genome-wide MyoD binding in skeletal muscle cells: a potential for broad cellular reprogramming.

Authors: Yi Cao; Zizhen Yao; Deepayan Sarkar; Michael Lawrence; Gilson J Sanchez; Maura H Parker; Kyle L MacQuarrie; Jerry Davison; Martin T Morgan; Walter L Ruzzo; Robert C Gentleman; Stephen J Tapscott
Journal: Dev Cell Date: 2010-04-20 Impact factor: 12.270

7. MyoD and E-protein heterodimers switch rhabdomyosarcoma cells from an arrested myoblast phase to a differentiated state.

Authors: Zhihong Yang; Kyle L MacQuarrie; Erwin Analau; Ashlee E Tyler; F Jeffery Dilworth; Yi Cao; Scott J Diede; Stephen J Tapscott
Journal: Genes Dev Date: 2009-03-15 Impact factor: 11.361

Review 8. Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas.

Authors: N J Sebire; M Malone
Journal: J Clin Pathol Date: 2003-06 Impact factor: 3.411

9. Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis.

Authors: S J Tapscott; M J Thayer; H Weintraub
Journal: Science Date: 1993-03-05 Impact factor: 47.728

10. The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3.

Authors: W J Fredericks; N Galili; S Mukhopadhyay; G Rovera; J Bennicelli; F G Barr; F J Rauscher
Journal: Mol Cell Biol Date: 1995-03 Impact factor: 4.272

1 in total

1. SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma.

Authors: Davide Martino Coda; Marcello Francesco Lingua; Deborah Morena; Valentina Foglizzo; Francesca Bersani; Ugo Ala; Carola Ponzetto; Riccardo Taulli
Journal: Cell Cycle Date: 2015 Impact factor: 4.534

1 in total